Extended Data Table 5.
Patient characteristics and outcomes according to hematopoietic cell transplantation-specific comorbidity index (HCT-CI) (<3 versus ≥ 3)
Data are n (%), unless otherwise specified.
*All samples previously diagnosed as high-grade B-cell lymphoma (double-hit/triple-hit/not otherwise specified) were classified as HGBCL with MYC-R and BCL2-R +/− BCL6-R (high-grade B-cell lymphoma with MYC and BCL2 rearrangements associated or not with BCL6 rearrangement) after central review.
#Grade ≥3 prolonged cytopenia was defined as a grade ≥3 laboratory result of anemia, neutropenia, and/or thrombocytopenia not resolved on day 30 after axi-cel infusion.
